LexDanaLexDanabeta
Inventor

Henrik Sune Andersen

Inventor
Lyngby, DK

Overview

63→
Patents
1993–2017
Patent span
Chemistry
Primary field (CPC C)

Patents· 63 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds35%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
A61KPreparations for medical, dental or toiletry purposes14%
C07CAcyclic or carbocyclic compounds5%
C07KPeptides3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
A61MDevices for introducing media into, or onto, the body1%
B05CApparatus for applying fluent materials to surfaces, in general1%
C12NMicroorganisms or enzymes1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
PatentTitleYear
9,737,612'Antagonistic DR3 ligands'20179,713,644'Antagonistic DR3 ligands'20179,695,226'Growth hormones with prolonged in-vivo efficacy'20178,865,868'Conjugated proteins with prolonged in vivo efficacy'20148,841,249'Growth hormones with prolonged in-vivo efficacy'20148,779,109'Growth hormones with prolonged in-vivo efficacy'20148,765,130'Antagonistic DR3 ligands'20148,383,668'11-beta-hydroxysteroid dehydrogenase type 1 active compounds'20138,383,683'Pharmaceutical use of substituted amides'20138,153,798'Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors'20128,138,342'11β-hydroxysteroid dehydrogenase type 1 active spiro compounds'20128,053,447'11β-hydroxysteroid dehydrogenase type 1 active compounds'20118,053,431'Pharmaceutical use of substituted amides'20118,048,908'11β-hydroxysteroid dehydrogenase type 1 active compounds'20117,723,323'Pharmaceutical use of fused 1,2,4-triazoles'20107,700,583'11β-hydroxysteroid dehydrogenase type 1 active compounds'20107,501,405'Combination therapy using an 11β-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent for the treatment of metabolic syndrome and related diseases and disorders'20097,358,238'Pharmaceutical use of fused 1,2,4-triazoles'20087,115,624'Method of inhibiting protein tyrosine phosphatase 1B and/or T-cell protein tyrosine phosphatase 4 and/or other PTPases with an Asp residue at position 48'20067,019,026'Modulators of Protein Tyrosine Phosphatases (PTPases)'20066,951,878'Benzo[b]thiophenyl or tetrahydro-benzo[b]thiophenyl modulators of protein tyrosine phosphatases (PTPases)'20056,796,970'Dose setting device'20046,613,903'Modulators of protein tyrosine phosphatases (PTPases)'20036,613,791'N-substituted azaheterocyclic carboxylic acids and their use'20036,410,556'Modulators of protein tyrosine phosphateses (PTPases)'20026,410,586'Modulators of protein tyrosine phosphatases (PTPases)'20026,262,044'Modulators of protein tyrosine phosphatases (PTPASES)'20016,239,148'N-substituted azaheterocyclic carboxylic acids and esters thereof'20016,225,329'Modulators of protein tyrosine phosphatases (PTPases)'20016,169,087'Modulators of protein tyrosine phosphatases (PTPases)'20016,166,009'N-substituted azaheterocyclic carboxylic acids and esters thereof'20006,127,343'Somatostatin agonists and antagonists'20006,110,913'N-substituted azaheterocyclic carboxylic acids and esters thereof'20006,080,770'Modulators of molecules with phosphotyrosine recognition units'20006,071,901'Substituted dibenz[b,f]azepines and uses thereof'20006,063,800'Modulators of molecules with phosphotyrosine recognition units'20006,043,247'Modulators of molecules with phosphotyrosine recognition units'20006,043,239'Heterocyclic compounds'20006,004,983'N-substituted azaheterocyclic compounds'19995,980,956'Deoxygenation of an oil product with a laccase'19995,972,978'Modulators of molecules with phosphotyrosine recognition units'19995,962,449'Tricyclic compounds in treating hyperalgesic conditions and NIDDM'19995,961,496'Syringe with tiltable nut for quick piston disengagement'19995,958,957'Modulators of molecules with phosphotyrosine recognition units'19995,952,352'Heterocyclic compounds'19995,874,428'N-substituted aza-heterocyclic carboxylic acids and esters thereof'19995,846,968'N-substituted azaheterocyclic carboxylic acids and esters'19985,827,856'Method of treating insulin resistance'19985,795,888'N-substituted azaheterocyclic carboxlic acids and esters thereof'19985,780,486'Heterocyclic compounds'19985,753,643'Heterocyclic compounds'19985,750,518'Heterocyclic compounds'19985,747,481'Heterocyclic compounds'19985,721,254'N-substituted azaheterocyclic carboxylic acids and esters thereof'19985,721,260'Heterocyclic compounds'19985,716,949'Heterocyclic compounds'19985,712,292'N-substituted azaheterocyclic carboxylic acids and esters thereof'19985,698,551'Heterocyclic compounds'19975,693,649'N-substituted azaheterocyclic carboxylic acids and esters thereof'19975,688,788'N-substituted azaheterocyclic carboxylic acids and esters thereof'19975,668,129'N-substituted azaheterocyclic carboxylic acids and esters thereof'19975,595,989'N-substituted azaheterocyclic carboxylic acids and esters thereof'19975,262,430'Substituted 2-imidazolines and use thereof'1993

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1993–2017Patents assigned to NOVO NORDISK AS (49)· patent assignee history
1997–2001Based in K.o slashed.benhavn, DK· patent location history
1997–2000Based in .O slashed.lstykke, DK· patent location history
1999–2003Based in Kobenhavn, DK· patent location history
2001–2014Based in Lyngby, DK· patent location history
2009–2013Patents assigned to HIGH POINT PHARMACEUTICALS LLC (9)· patent assignee history
2012–2017Patents assigned to ANDERSEN HENRIK SUNE (8)· patent assignee history
2012–2017Based in Holte, DK· patent location history
2014–2017Patents assigned to BUCHARDT JENS (3)· patent assignee history
2014–2017Patents assigned to JOHANSEN NILS LANGELAND (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
NOVO NORDISK AS491993–2017
HIGH POINT PHARMACEUTICALS LLC92009–2013
ANDERSEN HENRIK SUNEself82012–2017
BUCHARDT JENS32014–2017
JOHANSEN NILS LANGELAND32014–2017
Locations
LocationPatentsSpan
Lyngby, DK182001–2014
K.o slashed.benhavn, DK121997–2001
.O slashed.lstykke, DK91997–2000
Holte, DK82012–2017
Kobenhavn, DK41999–2003